{"id":"https://openalex.org/W4403719351","doi":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c","title":"S282 Real-World Use of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Adults With Recurrent Clostridioides difficile Infection in the United States","display_name":"S282 Real-World Use of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Adults With Recurrent Clostridioides difficile Infection in the United States","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403719351","doi":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0001030496.61161.3c","doi":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076449057","display_name":"Stuart Akerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120188","display_name":"Digestive Health Associates of Texas","ror":"https://ror.org/03m0npv78","country_code":"US","type":"other","lineage":["https://openalex.org/I4210120188"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stuart Akerman","raw_affiliation_strings":["Digestive Health Associates of Texas, Plano, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Digestive Health Associates of Texas, Plano, TX;","institution_ids":["https://openalex.org/I4210120188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114401122","display_name":"Ashish Gumaste","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738220","display_name":"Nestl\u00e9 Health Science (United States)","ror":"https://ror.org/03y8jvk69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112383","https://openalex.org/I4392738220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish Gumaste","raw_affiliation_strings":["Nestl\u00e9 Health Science, Bridgewater, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nestl\u00e9 Health Science, Bridgewater, NJ;","institution_ids":["https://openalex.org/I4392738220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100705946","display_name":"Michael J. Chen","orcid":"https://orcid.org/0000-0002-9557-4925","observed_orcids":["https://orcid.org/0000-0002-9557-4925"]},"institutions":[{"id":"https://openalex.org/I4392738220","display_name":"Nestl\u00e9 Health Science (United States)","ror":"https://ror.org/03y8jvk69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112383","https://openalex.org/I4392738220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Chen","raw_affiliation_strings":["Nestle Health Science, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nestle Health Science, Dallas, TX;","institution_ids":["https://openalex.org/I4392738220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lisa Connor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738220","display_name":"Nestl\u00e9 Health Science (United States)","ror":"https://ror.org/03y8jvk69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112383","https://openalex.org/I4392738220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Connor","raw_affiliation_strings":["Nestle Health Science, Lavallette, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nestle Health Science, Lavallette, NJ;","institution_ids":["https://openalex.org/I4392738220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067356779","display_name":"Maximilian von Eynatten","orcid":"https://orcid.org/0009-0006-8443-7323","observed_orcids":["https://orcid.org/0009-0006-8443-7323"]},"institutions":[{"id":"https://openalex.org/I4210112383","display_name":"Nestl\u00e9 (Switzerland)","ror":"https://ror.org/01v5xwf23","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210112383"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Maximilian von Eynatten","raw_affiliation_strings":["Nestle Health Science, Lausanne, Vaud, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nestle Health Science, Lausanne, Vaud, Switzerland;","institution_ids":["https://openalex.org/I4210112383"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jane De Vries","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane De Vries","raw_affiliation_strings":["Independent Health Economist, Bagshot, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Health Economist, Bagshot, England, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108926162","display_name":"Dianne Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738220","display_name":"Nestl\u00e9 Health Science (United States)","ror":"https://ror.org/03y8jvk69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112383","https://openalex.org/I4392738220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dianne Nguyen","raw_affiliation_strings":["Nestl\u00e9 Health Science, Bridgewater, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nestl\u00e9 Health Science, Bridgewater, NJ;","institution_ids":["https://openalex.org/I4392738220"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5076449057"],"corresponding_institution_ids":["https://openalex.org/I4210120188"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"119","issue":"10S","first_page":"S202","last_page":"S202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-clostridioides-difficile-infection","display_name":"recurrent Clostridium difficile infection","score":0.9309999942779541},{"id":"https://openalex.org/keywords/ser-109","display_name":"SER-109","score":0.8809999823570251},{"id":"https://openalex.org/keywords/vos","display_name":"VO","score":0.7829999923706055},{"id":"https://openalex.org/keywords/microbiome-based-therapy","display_name":"microbiota-based therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/real-world-applications","display_name":"real-world applications","score":0.8240000009536743},{"id":"https://openalex.org/keywords/repeat-prescribing","display_name":"repeat prescriptions","score":0.8949999809265137},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.6869999766349792},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":0.984000027179718},{"id":"https://openalex.org/keywords/antibiotic-associated-diarrhea","display_name":"antibiotic-associated diarrhea","score":0.46799999475479126},{"id":"https://openalex.org/keywords/patient-support-programs","display_name":"patient support services","score":0.5009999871253967},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.578000009059906},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C2910067853","wikidata":"https://www.wikidata.org/wiki/Q27438828","display_name":"Clostridioides","level":2,"score":0.9764047861099243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8213979005813599},{"id":"https://openalex.org/C61716771","wikidata":"https://www.wikidata.org/wiki/Q496","display_name":"Feces","level":2,"score":0.6887076497077942},{"id":"https://openalex.org/C137923570","wikidata":"https://www.wikidata.org/wiki/Q2121103","display_name":"Fecal bacteriotherapy","level":4,"score":0.5750336647033691},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5304414629936218},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.36267223954200745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22675171494483948},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11269143223762512},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.08916431665420532}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0001030496.61161.3c","doi":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001030496.61161.3c","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4406946818","https://openalex.org/W4389740290","https://openalex.org/W4403719567","https://openalex.org/W4403258185","https://openalex.org/W4402832376","https://openalex.org/W4400124157","https://openalex.org/W4417199115","https://openalex.org/W4392463455","https://openalex.org/W4403719733","https://openalex.org/W4381598996"],"abstract_inverted_index":{"Introduction:":[0],"Fecal":[1],"microbiota":[2,405],"spores,":[3,406],"live-brpk":[4,407],"(VOWST\u2122;":[5,408],"formerly":[6,409],"SER-109,":[7],"hereafter":[8],"referred":[9],"to":[10,20,102,161,174,232,296,305,328,336],"as":[11,35,99],"VOS)":[12],"is":[13],"an":[14],"FDA-approved":[15],"orally":[16],"administered":[17],"microbiome":[18],"therapeutic":[19],"prevent":[21,103,306],"recurrent":[22,401],"Clostridioides":[23,397],"difficile":[24,398],"infection":[25],"(rCDI)":[26],"in":[27,60,64,139,155,262,271,314,365,374],"adults":[28,61,123],"after":[29,52,57,268,310],"antibiotics":[30,59,228,311],"for":[31,39,163,210,229,312,331,362,386,388],"rCDI.":[32],"VOS,":[33,76,199,347,403],"taken":[34],"4":[36],"capsules":[37],"daily":[38],"3":[40],"consecutive":[41,281],"days,":[42],"significantly":[43],"reduced":[44],"rCDI":[45,48,63,125,230,364,387],"risk":[46],"(ie,":[47],"within":[49],"8":[50,269,352],"wks":[51,256,270,279],"study":[53,106,325],"drug)":[54],"vs":[55,78,234,241,247],"placebo":[56],"standard-of-care":[58],"with":[62,124,181,212,316],"the":[65,140,151,159,258,288,317,366],"randomized,":[66],"double-blind,":[67],"placebo-controlled":[68],"ECOSPOR":[69],"III":[70],"trial":[71],"by":[72],"68%":[73],"(rCDI":[74],"rate:":[75],"12%":[77],"placebo,":[79],"40%;":[80],"relative":[81],"risk,":[82],"0.32;":[83],"95%":[84],"CI,":[85],"0.18\u20130.58;":[86],"P":[87],"<":[88],"0.001)":[89],"(N":[90],"Engl":[91],"J":[92],"Med.":[93],"2022;386:220-229).":[94],"Pivotal":[95],"trials":[96],"evaluated":[97],"VOS":[98,127,131,185,204,216,236,251,260,282,293,303,333,360,373,381],"single":[100,182,213,233,320],"use":[101,108,217,237,261,294,382],"rCDI;":[104],"we":[105],"real-world":[107,292],"of":[109,136,179,257,265,274,278,291,300,308,323,372,390,393],"VOS.":[110,166,342],"Methods:":[111],"This":[112],"retrospective,":[113],"observational":[114],"analysis":[115],"assessed":[116],"patient":[117],"(pt)":[118],"and":[119,128,144,214,220,244,267,369],"dispensing":[120],"data":[121],"from":[122,132,150,170],"prescribed":[126,227],"who":[129],"received":[130,202,254,302,349],"a":[133],"limited":[134],"network":[135],"specialty":[137],"pharmacies":[138],"United":[141],"States.":[142],"Demographics":[143],"clinical":[145,375],"characteristics":[146],"were":[147,168,187,190,238],"also":[148],"obtained":[149],"pt":[152],"support":[153],"program,":[154],"which":[156],"patients":[157,180,197,211,266,301,344],"had":[158],"option":[160],"enroll":[162],"assistance":[164],"acquiring":[165],"Data":[167,189],"analyzed":[169,191],"June":[171],"5,":[172],"2023,":[173],"May":[175],"31,":[176],"2024.":[177],"Proportions":[178],"or":[183,335,379],"repeat":[184,203,215,235,332,346,380],"prescriptions":[186,205,334],"identified.":[188],"descriptively.":[192],"Results:":[193],"Of":[194,343],"3820":[195],"unique":[196],"receiving":[198,341,345],"1.9%":[200],"(n=71)":[201],"(Figure":[206],"1).":[207],"Mean":[208],"age":[209],"was":[218,253,284],"67.8":[219],"74.3":[221],"years,":[222],"respectively.":[223],"Most":[224],"frequently":[225],"(\u226520%)":[226],"prior":[231,259],"vancomycin":[239],"(49.1%":[240],"53.0%,":[242],"respectively)":[243],"fidaxomicin":[245],"(26.2%":[246],"25.5%).":[248],"A":[249],"subsequent":[250],"prescription":[252],"\u22648":[255],"0.5%":[263],"(n=21)":[264],"1.3%":[272],"(n=50)":[273],"patients.":[275],"Median":[276],"number":[277],"between":[280],"uses":[283],"13.":[285],"Conclusion:":[286],"In":[287],"largest":[289],"dataset":[290],"available":[295],"date,":[297],"over":[298],"98%":[299],"once":[304],"recurrence":[307,392],"CDI":[309],"rCDI,":[313,400],"accordance":[315],"drug\u2019s":[318],"intended":[319],"use.":[321],"Limitations":[322],"our":[324],"include":[326],"inability":[327],"determine":[329],"reasons":[330],"capture":[337],"enrolled":[338],"individuals":[339],"not":[340],"most":[348],"it":[350],"beyond":[351],"wks,":[353],"suggesting":[354],"new/distinct":[355],"infection.":[356],"These":[357],"observations":[358],"reveal":[359],"effectiveness":[361],"preventing":[363],"real":[367],"world":[368],"support/contextualize":[370],"efficacy":[371],"trials.Figure":[376],"1.:":[377],"Single":[378],"following":[383],"antibiotic":[384],"treatment":[385],"prevention":[389],"future":[391],"CDI.":[394],"Abbreviations:":[395],"CDI,":[396],"infection;":[399],"CDI;":[402],"fecal":[404],"SER-109).":[410]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-10-25T00:00:00"}